ANGELICA TIMMERMAN: Open Payments
NPI 1134505993 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$633 in 28 payments from 12 companies in 2025. Trend: 2023 $271 · 2024 $749 · 2025 $633
Food & beverage: $633
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $173 |
| PFIZER INC. | 5 | $104 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $61 |
| Amgen Inc. | 3 | $56 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $56 |
| Novo Nordisk Inc | 2 | $40 |
| Axsome Therapeutics, Inc. | 2 | $33 |
| Eisai Inc. | 1 | $28 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $20 |
Products named: ZEPBOUND, NURTEC ODT, JARDIANCE, TRINTELLIX, OTEZLA, MOUNJARO, Auvelity, Leqembi.
Industry payments across GA — which companies pay providers there.
